Dr. Thomas Jiang, M.D.
Pulmonology (Pulmonary Disease Physician)
3828 Schaufele Ave Ste 200
Long Beach, CA 90808
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (2010)
- Years since graduation
- 16
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 362
Licensed in California since 2011, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2010Medical school: Washington University School of Medicine
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
CA license A119331 (first issued 2011; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorialcare Long Beach Medical Center Long Beach, CA
Medical groups
- Memorialcare Medical Foundation (566 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 362
- Services billed
- 1,464
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 276 | 152 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 200 | 78 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 148 | 56 |
| Critical care, first 30-74 minutes | 100 | 36 |
| Test to examine how well the lungs exchange gases | 68 | 66 |
| Test to determine lung volumes using sensors | 66 | 64 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 64 | 62 |
| Test for exercise-induced lung stress | 46 | 44 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 41 | 37 |
| Test to measure expiratory airflow and volume | 37 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Long Beach, CA | 180 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Long Beach, CA | 147 |
| Montelukast Sodium Other prescribers in Long Beach, CA | 123 |
| Azithromycin Other prescribers in Long Beach, CA | 79 |
| Prednisone Other prescribers in Long Beach, CA | 64 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Long Beach, CA | 51 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Long Beach, CA | 46 |
| Dupixent Pen (dupilumab) Other prescribers in Long Beach, CA | 36 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Long Beach, CA | 36 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Long Beach, CA | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 16 payments worth $429 in total to this clinician.
| GlaxoSmithKline, LLC. | $243 |
|---|---|
| Amgen Inc. | $87.45 |
| Merck Sharp & Dohme LLC | $30.16 |
| AstraZeneca Pharmaceuticals LP | $24.96 |
| Inspire Medical Systems, Inc. | $22.78 |
| Insmed, Inc. | $20.82 |
| Food and Beverage | $429 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.